Budesonide?(BUD), sold under the brand name?Pulmicort?among others, is a medication of the corticosteroid type.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Budesonide (BUD) industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Nasal Spray
Inhaler
Pill&Rectal Forms
Market Segment by Product Application
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment
Finally, the report provides detailed profile and data information analysis of leading company.
AstraZeneca
Cosmo Pharmaceuticals
Teva
Mylan
Sandoz
Dr. Falk Pharma
Chiesi Farmaceutici S.p.A
Orion Corporation
Cipla
Synmosa Biopharma Corporation
Lunan Better Pharmaceutical
Shanghai Sine Promod Pharmaceutical
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Budesonide (BUD) consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Budesonide (BUD) market by identifying its various subsegments.
3.Focuses on the key global Budesonide (BUD) manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Budesonide (BUD) with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Budesonide (BUD) submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Budesonide (BUD) Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Budesonide (BUD) Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Budesonide (BUD) Segment by Type
2.1.1 Nasal Spray
2.1.2 Inhaler
2.1.3 Pill&Rectal Forms
2.2 Market Analysis by Application
2.2.1 Respiratory Disease Treatment
2.2.2 Nose Disease Treatment
2.2.3 Inflammatory Bowel Disease Treatment
2.3 Global Budesonide (BUD) Market Comparison by Regions (2017-2027)
2.3.1 Global Budesonide (BUD) Market Size (2017-2027)
2.3.2 North America Budesonide (BUD) Status and Prospect (2017-2027)
2.3.3 Europe Budesonide (BUD) Status and Prospect (2017-2027)
2.3.4 China Budesonide (BUD) Status and Prospect (2017-2027)
2.3.5 Japan Budesonide (BUD) Status and Prospect (2017-2027)
2.3.6 Southeast Asia Budesonide (BUD) Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Budesonide (BUD) Industry Impact
2.5.1 Budesonide (BUD) Business Impact Assessment - Covid-19
2.5.2 Market Trends and Budesonide (BUD) Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Budesonide (BUD) Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Budesonide (BUD) Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Budesonide (BUD) Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Budesonide (BUD) Manufacturer Market Share
3.5 Top 10 Budesonide (BUD) Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Budesonide (BUD) Market
3.7 Key Manufacturers Budesonide (BUD) Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Budesonide (BUD) Industry Key Manufacturers
4.1 AstraZeneca
4.1.1 Compan Detail
4.1.2 AstraZeneca Budesonide (BUD) Product Introduction, Application and Specification
4.1.3 AstraZeneca 160 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 AstraZeneca News
4.2 Cosmo Pharmaceuticals
4.2.1 Compan Detail
4.2.2 Cosmo Pharmaceuticals Budesonide (BUD) Product Introduction, Application and Specification
4.2.3 Cosmo Pharmaceuticals Budesonide (BUD) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 AstraZeneca News
4.3 Teva
4.3.1 Compan Detail
4.3.2 Teva Budesonide (BUD) Product Introduction, Application and Specification
4.3.3 Teva Budesonide (BUD) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Teva News
4.4 Mylan
4.4.1 Compan Detail
4.4.2 Mylan Budesonide (BUD) Product Introduction, Application and Specification
4.4.3 Mylan Budesonide (BUD) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Mylan News
4.5 Sandoz
4.5.1 Compan Detail
4.5.2 Mylan Budesonide (BUD) Product Introduction, Application and Specification
4.5.3 Sandoz Budesonide (BUD) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Sandoz News
4.6 Dr. Falk Pharma
4.6.1 Compan Detail
4.6.2 Dr. Falk Pharma Budesonide (BUD) Product Introduction, Application and Specification
4.6.3 Dr. Falk Pharma Budesonide (BUD) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Dr. Falk Pharma News
4.7 Chiesi Farmaceutici S.p.A
4.7.1 Compan Detail
4.7.2 Chiesi Farmaceutici S.p.A Budesonide (BUD) Product Introduction, Application and Specification
4.7.3 Chiesi Farmaceutici S.p.A Budesonide (BUD) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Orion Corporation
4.8.1 Compan Detail
4.8.2 Orion Corporation Budesonide (BUD) Product Introduction, Application and Specification
4.8.3 Orion Corporation Budesonide (BUD) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Orion Corporation News
4.9 Cipla
4.9.1 Compan Detail
4.9.2 Cipla Budesonide (BUD) Product Introduction, Application and Specification
4.9.3 Cipla Budesonide (BUD) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Cipla News
4.10 Synmosa Biopharma Corporation
4.10.1 Compan Detail
4.10.2 Synmosa Biopharma Corporation Budesonide (BUD) Product Introduction, Application and Specification
4.10.3 Synmosa Biopharma Corporation Budesonide (BUD) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Synmosa Biopharma Corporation News
4.11 Lunan Better Pharmaceutical
4.11.1 Compan Detail
4.11.2 Lunan Better Pharmaceutical Budesonide (BUD) Product Introduction, Application and Specification
4.11.3 Lunan Better Pharmaceutical Budesonide (BUD) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Lunan Better Pharmaceutical News
4.12 Shanghai Sine Promod Pharmaceutical
4.12.1 Compan Detail
4.12.2 Shanghai Sine Promod Pharmaceutical Budesonide (BUD) Product Introduction, Application and Specification
4.12.3 Shanghai Sine Promod Pharmaceutical Budesonide (BUD) Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Shanghai Sine Promod Pharmaceutical News
5 Global Budesonide (BUD) Market Segment by Big Type
5.1 Global Budesonide (BUD) Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Budesonide (BUD) Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Budesonide (BUD) Revenue and Market Share by Big Type (2017-2022)
5.2 Nasal Spray Sales Growth Rate and Price
5.2.1 Global Nasal Spray Sales Growth Rate (2017-2022)
5.2.2 Global Nasal Spray Price (2017-2022)
5.3 Inhaler Sales Growth Rate and Price
5.3.1 Global Inhaler Sales Growth Rate (2017-2022)
5.3.2 Global Inhaler Price (2017-2022)
5.4 Pill&Rectal Forms Sales Growth Rate and Price
5.4.1 Global Pill&Rectal Forms Sales Growth Rate (2017-2022)
5.4.2 Global Pill&Rectal Forms Price (2017-2022)
6 Global Budesonide (BUD) Market Segment by Big Application
6.1 Global Budesonide (BUD) Sales Market Share by Big Application (2017-2022)
6.2 Respiratory Disease Treatment Sales Growth Rate (2017-2022)
6.3 Nose Disease Treatment Sales Growth Rate (2017-2022)
6.4 Inflammatory Bowel Disease Treatment Sales Growth Rate (2017-2022)
7 Global Budesonide (BUD) Forecast
7.1 Global Budesonide (BUD) Revenue, Sales and Growth Rate (2022-2027)
7.2 Budesonide (BUD) Market Forecast by Regions (2022-2027)
7.2.1 North America Budesonide (BUD) Market Forecast (2022-2027)
7.2.2 Europe Budesonide (BUD) Market Forecast (2022-2027)
7.2.3 China Budesonide (BUD) Market Forecast (2022-2027)
7.2.4 Japan Budesonide (BUD) Market Forecast (2022-2027)
7.2.5 Southeast Asia Budesonide (BUD) Market Forecast (2022-2027)
7.2.6 Other Regions Budesonide (BUD) Market Forecast (2022-2027)
7.3 Budesonide (BUD) Market Forecast by Type (2022-2027)
7.3.1 Global Budesonide (BUD) Sales Forecast by Type (2022-2027)
7.3.2 Global Budesonide (BUD) Market Share Forecast by Type (2022-2027)
7.4 Budesonide (BUD) Market Forecast by Application (2022-2027)
7.4.1 Global Budesonide (BUD) Sales Forecast by Application (2022-2027)
7.4.2 Global Budesonide (BUD) Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Budesonide (BUD) Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Budesonide (BUD) Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Budesonide (BUD)
Figure Market Concentration Ratio and Market Maturity Analysis of Budesonide (BUD)
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Budesonide (BUD) Market Size by Big Type
Figure Global Market Share of Budesonide (BUD) by Big Type in 2021
Figure Nasal Spray Picture (2017-2022)
Figure Inhaler Picture (2017-2022)
Global Budesonide (BUD) Market Size by Big Application
Table Global Budesonide (BUD) Market Size by Application
Figure Global Budesonide (BUD) Market Share by Big Application in 2021
Figure Respiratory Disease Treatment Picture
Figure Nose Disease Treatment Picture
Figure Inflammatory Bowel Disease Treatment Picture
Table Global Budesonide (BUD) Comparison by Regions (M USD) (2017-2027)
Figure Global Budesonide (BUD) Market Size (Million US$) (2017-2027)
Figure North America Budesonide (BUD) Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Budesonide (BUD) Revenue (Million US$) Growth Rate (2017-2027)
Figure China Budesonide (BUD) Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Budesonide (BUD) Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Budesonide (BUD) Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Budesonide (BUD) Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Budesonide (BUD) Sales by Manufacturer (2017-2022)
Figure Global Budesonide (BUD) Sales Market Share by Manufacturer in 2021
Table Global Budesonide (BUD) Revenue by Manufacturer (2017-2022)
Figure Global Budesonide (BUD) Revenue Market Share by Manufacturer in 2021
Table Global Budesonide (BUD) Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Budesonide (BUD) Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Budesonide (BUD) Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Budesonide (BUD) Market
Table Key Manufacturers Budesonide (BUD) Product Type
Table Mergers & Acquisitions Planning
Table AstraZeneca Company Profile
Table Budesonide (BUD) Product Introduction, Application and Specification of AstraZeneca
Table Budesonide (BUD) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Cosmo Pharmaceuticals Company Profile
Table Budesonide (BUD) Product Introduction, Application and Specification of Cosmo Pharmaceuticals
Table Budesonide (BUD) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Cosmo Pharmaceuticals Recent Development
Table Teva Company Profile
Table Budesonide (BUD) Product Introduction, Application and Specification of Teva
Table Budesonide (BUD) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Teva Main Business
Table Teva Recent Development
Table Mylan Company Profile
Table Budesonide (BUD) Product Introduction, Application and Specification of Mylan
Table Budesonide (BUD) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Mylan Main Business
Table Mylan Recent Development
Table Mylan Main Business
Table Mylan Recent Development
Table Sandoz Company Profile
Table Budesonide (BUD) Product Introduction, Application and Specification of Sandoz
Table Budesonide (BUD) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sandoz Main Business
Table Sandoz Recent Development
Table Dr. Falk Pharma Company Profile
Table Budesonide (BUD) Product Introduction, Application and Specification of Dr. Falk Pharma
Table Budesonide (BUD) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Dr. Falk Pharma Main Business
Table Dr. Falk Pharma Recent Development
Table Chiesi Farmaceutici S.p.A Company Profile
Table Budesonide (BUD) Product Introduction, Application and Specification of Chiesi Farmaceutici S.p.A
Table Budesonide (BUD) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Chiesi Farmaceutici S.p.A Main Business
Table Chiesi Farmaceutici S.p.A Recent Development
Table Orion Corporation Company Profile
Table Budesonide (BUD) Product Introduction, Application and Specification of Orion Corporation
Table Budesonide (BUD) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Orion Corporation Main Business
Table Orion Corporation Recent Development
Table Cipla Company Profile
Table Budesonide (BUD) Product Introduction, Application and Specification of Cipla
Table Budesonide (BUD) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Cipla Main Business
Table Cipla Recent Development
Table Synmosa Biopharma Corporation Company Profile
Table Budesonide (BUD) Product Introduction, Application and Specification of Synmosa Biopharma Corporation
Table Budesonide (BUD) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Synmosa Biopharma Corporation Main Business
Table Synmosa Biopharma Corporation Recent Development
Table Lunan Better Pharmaceutical Company Profile
Table Budesonide (BUD) Product Introduction, Application and Specification of Lunan Better Pharmaceutical
Table Budesonide (BUD) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Lunan Better Pharmaceutical Main Business
Table Lunan Better Pharmaceutical Recent Development
Table Shanghai Sine Promod Pharmaceutical Company Profile
Table Budesonide (BUD) Product Introduction, Application and Specification of Shanghai Sine Promod Pharmaceutical
Table Budesonide (BUD) Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Shanghai Sine Promod Pharmaceutical Main Business
Table Shanghai Sine Promod Pharmaceutical Recent Development
Figure Global Budesonide (BUD) Sales and Growth Rate (2017-2022)
Figure Global Budesonide (BUD) Revenue and Growth Rate (2017-2022)
Table Global Budesonide (BUD) Sales by Regions (2017-2022)
Figure Global Budesonide (BUD) Sales Market Share by Regions in 2021
Table Global Budesonide (BUD) Revenue by Regions (2017-2022)
Figure Global Budesonide (BUD) Revenue Market Share by Regions in 2021
Figure North America Budesonide (BUD) Sales and Growth Rate (2017-2022)
Figure Europe Budesonide (BUD) Sales and Growth Rate (2017-2022)
Figure China Budesonide (BUD) Sales and Growth Rate (2017-2022)
Figure Japan Budesonide (BUD) Sales and Growth Rate (2017-2022)
Figure Southeast Asia Budesonide (BUD) Sales and Growth Rate (2017-2022)
Figure Other Regions Budesonide (BUD) Sales and Growth Rate (2017-2022)
Table Global Budesonide (BUD) Sales by Big Type (2017-2022)
Table Global Budesonide (BUD) Sales Market Share by Big Type (2017-2022)
Figure Global Budesonide (BUD) Sales Market Share by Big Type in 2019
Table Global Budesonide (BUD) Revenue by Big Type (2017-2022)
Table Global Budesonide (BUD) Revenue Market Share by Big Type (2017-2022)
Table Global Budesonide (BUD) Revenue Market Share by Big Type in 2019
Figure Global Nasal Spray Sales Growth Rate (2017-2022)
Figure Global Nasal Spray Price (2017-2022)
Figure Global Inhaler Sales Growth Rate (2017-2022)
Figure Global Inhaler Price (2017-2022)
Figure Global Pill&Rectal Forms Sales Growth Rate (2017-2022)
Table Global Budesonide (BUD) Sales by Big Application (2017-2022)
Table Global Budesonide (BUD) Sales Market Share by Big Application (2017-2022)
Figure Global Budesonide (BUD) Sales Market Share by Big Application in 2019
Figure Global Respiratory Disease Treatment Sales Growth Rate (2017-2022)
Figure Global Nose Disease Treatment Sales Growth Rate (2017-2022)
Figure Global Inflammatory Bowel Disease Treatment Sales Growth Rate (2017-2022)
Figure Global Budesonide (BUD) Sales and Growth Rate (2022-2027)
Figure Global Budesonide (BUD) Revenue and Growth Rate (2022-2027)
Table Global Budesonide (BUD) Sales Forecast by Regions (2022-2027)
Table Global Budesonide (BUD) Market Share Forecast by Regions (2022-2027)
Figure North America Sales Budesonide (BUD) Market Forecast (2022-2027)
Figure Europe Sales Budesonide (BUD) Market Forecast (2022-2027)
Figure China Sales Budesonide (BUD) Market Forecast (2022-2027)
Figure Japan Sales Budesonide (BUD) Market Forecast (2022-2027)
Figure Southeast Asia Sales Budesonide (BUD) Market Forecast (2022-2027)
Figure Other Regions Sales Budesonide (BUD) Market Forecast (2022-2027)
Table Global Budesonide (BUD) Sales Forecast by Type (2022-2027)
Table Global Budesonide (BUD) Market Share Forecast by Type (2022-2027)
Table Global Budesonide (BUD) Sales Forecast by Application (2022-2027)
Table Global Budesonide (BUD) Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Budesonide (BUD)
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Budesonide (BUD) Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Budesonide (BUD) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Budesonide (BUD) Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Budesonide (BUD) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Budesonide (BUD) Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Budesonide (BUD) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Budesonide (BUD) Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Budesonide (BUD) Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
AstraZeneca
Cosmo Pharmaceuticals
Teva
Mylan
Sandoz
Dr. Falk Pharma
Chiesi Farmaceutici S.p.A
Orion Corporation
Cipla
Synmosa Biopharma Corporation
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)